We demonstrated very high sensitivity and specificity of the approach and also provided an explanation as to why the pharmacokinetic properties of [18F]BF4− are better suited for studying NIS-expressing tumor models than those of radioiodine. This evidence concerns the gene SLC5A5 and neoplasm.